indazoles has been researched along with Central Nervous System Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comery, TA; Di, L; Kerns, EH; Kowal, DM; Liu, KG; Lo, JR; Robichaud, AJ; Schechter, LE; Smith, DL; Zhang, GM; Zhang, JY | 1 |
1 other study(ies) available for indazoles and Central Nervous System Disease
| Article | Year |
|---|---|
1-Sulfonylindazoles as potent and selective 5-HT6 ligands.
Topics: Administration, Oral; Animals; Biological Availability; Central Nervous System Diseases; Cognition Disorders; Drug Design; Humans; Indazoles; Inhibitory Concentration 50; Kinetics; Ligands; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin | 2009 |